New legal opinion: New GMOs deregulation proposal shifts safety testing, liability to EU food industry
By GMWatch Staff,
GMWatch
| 01. 14. 2025
Photo by Markus Winkler on Unsplash
The planned deregulation of new GMOs (new genomic techniques, NGTs) in the EU would shift safety testing and liability risks for plants produced with NGTs and the products derived from them, from biotech companies to the food industry. These consequences, until now unnoticed, of the EU Commission's plans to deregulate new GMOs are highlighted in a new legal opinion by the Berlin law firm GGSC on behalf of ENGA’s member VLOG (German Association for Food without Genetic Engineering). ENGA is the voice of the Non-GMO food and feed sector at the EU level.
EU Commission’s plans to deregulate new GMOs are to the detriment of the EU food sector
Heike Moldenhauer, Secretary General of ENGA, said: “With its plans to deregulate New GMOs, the European Commission is throwing the EU’s food sector ‘to the wolves’, by shifting the costs and risks from biotech to the food sector. This is unacceptable and may become a major problem for the entire EU food industry, not just the organic and ‘Non-GMO’ sectors.”
Biotechnology companies must take responsibility...
Related Articles
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Carter Sherman, The Guardian | 12.08.2025
A huge defense policy bill, revealed by US lawmakers on Sunday, does not include a provision that would have provided broad healthcare coverage for in vitro fertilization (IVF) for active-duty members of the military, despite Donald Trump’s pledge...
